Also, Xuan et al. [49] indicated that HIF1α provides a selective advantage in hypoxia by inducing genes associated with angiogenesis and drug transporter proteins and its level can be a predictive factor of the effectiveness of 5-FU-based adjuvant chemotherapy in gastric cancer. This evidence concerns the gene HIF1A and gastric cancer.